Evidence map›Paper›PMID 35433597›Full record

ArticleFrontiers in public health2022

Approximation to the Consumption of Healthcare Resources and the Economic Cost of SARS-CoV-2 Patient Management: A Retrospective Study.

Jesús Calderón-Moreno, Raúl Juárez-Vela, María Jesús Delgado-Rodríguez, Manuel Quintana-Díaz, Rosa Magallón-Botaya, Bárbara Olivan-Blázquez, Ana Cobos-Rincón, Iván Santolalla-Arnedo, Carmen Amaia Ramírez-Torres, Vicente Gea-Caballero and 1 more

Abstract read
In one paragraph

Article in Frontiers in public health, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Article
  2. Article
  3. Review
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Jesús Calderón-MorenoBusiness Economics Department, University of Rey Juan Carlos, Madrid, Spain.
Raúl Juárez-VelaDepartment of Nursing, GRUPAC, University of La Rioja, Logroño, Spain.
María Jesús Delgado-RodríguezBusiness Economics Department, University of Rey Juan Carlos, Madrid, Spain.
Manuel Quintana-DíazResearch Group Blood Patient Management, IDI-Paz Research Institute, Madrid, Spain.
Rosa Magallón-BotayaPrimary Care Prevention and Health Promotion Network, Research Unit in Primary Care, IIS Aragón, University of Zaragoza, Zaragoza, Spain.
Bárbara Olivan-BlázquezDepartment of Psychology and Sociology, Institute for Health Research Aragón (IISA), University of Zaragoza, Zaragoza, Spain.
Ana Cobos-RincónDepartment of Nursing, GRUPAC, University of La Rioja, Logroño, Spain.
Iván Santolalla-ArnedoDepartment of Nursing, GRUPAC, University of La Rioja, Logroño, Spain.
Carmen Amaia Ramírez-TorresDepartment of Nursing, GRUPAC, University of La Rioja, Logroño, Spain.
Vicente Gea-CaballeroResearch Group Blood Patient Management, IDI-Paz Research Institute, Madrid, Spain.
Eva María Andrés-EstebanBusiness Economics Department, University of Rey Juan Carlos, Madrid, Spain.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Spain has become one of the countries most affected by coronavirus disease 2019 (COVID-19), with the highest testing rates, and one of the worst-performing countries in the fight against the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) pandemic. There are no studies related to the consumption of health resources and the economic cost of the SARS-CoV-2 virus. We present a retrospective analysis of 9,811 (Primary Care and Hospital) patients which aimed to estimate public health expenditure by the consumption of health resources due to COVID-19. According to the results, the gender distribution of patients has a similar rate in both groups, with slightly higher rates in women. Similarly, age is the same in both groups, with a median of 62 years in the case of hospitalizations and 61 years in the case of primary care; using a weighted average of these rates and costs, we can estimate that the average cost of care per patient infected with the SARS-CoV-2 virus, regardless of the course is €2373.24. We conclude that a patient with COVID-19 without hospitalization costs €729.79, while the expenses of a hospitalized patient are between €4294.36 and €14440.68, if there is ICU admission.

Indexed as

COVID-19SARS-CoV-2Delivery of Health CareFemaleHumansMiddle AgedPandemicsRetrospective Studiescoronavirus infectionscost control and cost managementCOVID-19health economicsSARS-CoV-2

Identifiers

PMID35433597
PMCPMC9008573

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.